Pharmacology, Toxicology and Pharmaceutical Science
Glucose
98%
Non Insulin Dependent Diabetes Mellitus
92%
Drug
87%
Metformin
84%
Placebo
66%
Hypoglycemia
61%
Hyperglycemia
59%
Sodium Glucose Cotransporter 2 Inhibitor
50%
Randomized Controlled Trial
48%
Clinical Trial
44%
Adverse Event
43%
Hydrocortisone
42%
Pharmacokinetics
42%
Generic Drug
42%
Combination Therapy
42%
Pulmonary Hypertension
42%
Controlled Clinical Trial
42%
Endothelin Receptor Antagonist
42%
Antiinfective Agent
42%
Proton Pump Inhibitor
42%
Psoriatic Arthritis
42%
Addison Disease
42%
Hemodialysis
42%
Methotrexate
42%
Connective Tissue Disease
42%
Hospital Acquired Pneumonia
42%
Drug Safety
42%
Insulin
37%
Monotherapy
34%
Aminoglycoside
28%
Dipeptidyl Carboxypeptidase Inhibitor
28%
Adverse Drug Reaction
28%
Angioneurotic Edema
28%
Vancomycin
21%
Clarithromycin
21%
Lincosamide
21%
Daptomycin
21%
Linezolid
21%
Macrolide
21%
Moxifloxacin
21%
Ofloxacin
21%
Erythromycin
21%
Cotrimoxazole
21%
Amikacin
21%
Trimethoprim
21%
Fosfomycin
21%
Teicoplanin
21%
Azithromycin
21%
Ciprofloxacin
21%
Polymyxin
21%
Medicine and Dentistry
Therapeutic Procedure
100%
Glucose
98%
Maturity Onset Diabetes of the Young
92%
Sodium Glucose Cotransporter 2 Inhibitor
92%
Inpatient
79%
Patient
63%
Hypoglycemia
57%
Mechanism of Action
56%
Polyuria
56%
Adverse Event
55%
Combination Therapy
52%
Meta-Analysis
49%
Systematic Review
49%
Older People
42%
Diabetes Mellitus in Pregnancy
42%
Pulmonary Hypertension
42%
Endothelin Receptor Antagonist
42%
Proton-Pump Inhibitor
42%
Glycon
42%
Connective Tissue Disease
42%
Older Adult
42%
Stress Hyperglycemia
42%
Blood Glucose
42%
Hospital-Acquired Pneumonia
42%
Desmopressin
42%
Insulin
37%
Hyperglycemia
36%
Drug
35%
Chemotherapeutic Agent
35%
Monotherapy
34%
Woman
25%
Drug Therapy
22%
Depletion
21%
Nephropathy
21%
Hypovolemia
21%
Plasma
16%
Age
15%
Insulin Resistance
15%
Urinary Tract Infection
15%
Heart Failure
14%
Patient with Type 2 Diabetes
14%
Cardiovascular Disease
14%
All Cause Mortality
14%
Mortality Rate
14%
Placebo
10%
Odds Ratio
10%
Phosphodiesterase V Inhibitor
10%
Renin
10%
Diabetes Insipidus
10%
Indicator
10%
Nursing and Health Professions
Psoriatic Arthritis
84%
Methotrexate
84%
Drug
84%
Glucose Blood Level
84%
Placebo
76%
Hypoglycemia
63%
Hyperglycemia
52%
Meta Analysis
51%
Monotherapy
47%
Pain
44%
Combination Therapy
44%
Adverse Event
42%
Statin (Protein)
42%
Clinical Practice
42%
Infusion Therapy
42%
Sodium Glucose Cotransporter Inhibitor
42%
Malignant Neoplasm
42%
Hydrocortisone
42%
Proton Pump Inhibitor
42%
Cross-Sectional Study
42%
Older People
42%
Uncertainty
42%
Glucose
42%
Endothelin Receptor Antagonist
42%
Connective Tissue Disease
42%
Pulmonary Hypertension
42%
Insulin
26%
Adult
25%
Glucose Urine Level
21%
Genital Tract Infection
21%
Urinary Tract Infection
21%
Insulin Resistance
21%
Dehydration
21%
Cotransporter
21%
Sodium Glucose Cotransporter 2 Inhibitor
21%
Non Insulin Dependent Diabetes Mellitus
21%
Odds Ratio
21%
Confidence Interval
20%
Health Status
20%
Clinical Outcome
19%
Infusion
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
15%
Prevalence
15%
Walking Distance
15%
Embase
14%
Drug Therapy
12%
Medline
12%
Quality of Life
12%
Visual Analog Scale
10%
Phosphodiesterase V Inhibitor
10%